1. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;C, LeRoy E.; M, Black C.; R, Fleischmajer;J Rheumatol,1988
2. Lymphocytes in the skin of patients with progressive systemic sclerosis;D, Roumm A.; L, Whiteside T.; A, Jr, Medsger T.; P, Rodnan G.;Arthritis Rheum,1984
3. Elevated expression of P11 and 12 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset;Sollberg, S.; Peltonen, J.; Uitto, J.; A, Jimenez S.;Arthritis Rheum,1992
4. Expression of inter-cellular adhesion molecule-I (ICAM-1) in the skin of patients with systemic scleroderma;Majeewski, S.; Hunzelmann, N.; P, Johnson J.,1991
5. Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis;Hawrylko, E.; Spertus, A.; A, Mele C.; Oster, N.; Frieri, M.;Arthritis Rheum,1991